Prescription drugs with potential for misuse in Irish prisons: analysis of national prison prescribing trends, by gender and history of opioid use disorder, 2012 to 2020

Abstract Background Pharmacotherapy is essential for the delivery of an equivalent standard of care in prison. Prescribing can be challenging due to the complex health needs of prisoners and the risk of misuse of prescription drugs. This study examines prescribing trends for drugs with potential for...

Full description

Bibliographic Details
Published in:	BMC Psychiatry
Main Authors:	Louise Durand, Eamon Keenan, Deirdre O’Reilly, Kathleen Bennett, Andy O’Hara, Gráinne Cousins
Format:	Article
Language:	English
Published:	BMC 2023-10-01
Subjects:	Prison prescribing Prescription opioids Benzodiazepines Z-drugs Gabapentinoids Opioid use disorder
Online Access:	https://doi.org/10.1186/s12888-023-05195-9

Similar Items

The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.
by: Chrianna Bharat, et al.
Published: (2022-08-01)

Misuse of prescription medicines is as prevalent as the use of recreational drugs and novel psychoactive substances in Singapore: an unrecognised public health issue?
by: Wui Ling Chan, et al.
Published: (2022-10-01)

The effects of opioid policy changes on transitions from prescription opioids to heroin, fentanyl and injection drug use: a qualitative analysis
by: Julia Dickson-Gomez, et al.
Published: (2022-07-01)

Concurrent Prescription Fills of Opioids and Benzodiazepines Among Postpartum Women During COVID-19
by: Amanda J. Abraham, PhD, et al.
Published: (2024-08-01)

Prescription of potentially addictive medications after a multilevel community intervention in general practice
by: Muhunthan Navaratnam, et al.
Published: (2023-01-01)

Cost-effective interventions to prevent prescription drug misuse: a systematic review
by: L. Yesenia Rodríguez-Tanta, et al.
Published: (2025-03-01)

A spatiotemporal analysis of opioid prescriptions in Indiana from 2015 to 2019
by: Paula A. Jaimes-Buitron, et al.
Published: (2025-08-01)

Use and misuse of psychoactive medicines: a descriptive cross-sectional study in a densely populated region of Portugal
by: Ana Carmona Araújo, et al.
Published: (2024-12-01)

Acute poisoning related to the recreational use of prescription drugs: an observational study from Oslo, Norway
by: Marit Mæhle Grimsrud, et al.
Published: (2019-10-01)

The association between benzodiazepine co-prescription, opioid agonist treatment and mortality: a systematic review
by: Christine Hillestad Hestevik, et al.
Published: (2024-10-01)

The Association between COVID-19 and Changes in Opioid Prescribing Patterns and Opioid-Related Overdoses: A Retrospective Cohort Study
by: Alexandra Robins, et al.
Published: (2023-12-01)

Management and evolution of insomnia among non-substance-misusers in a Swiss remand prison
by: Swiss Medical Weekly
Published: (2004-08-01)

Clinical Outcomes of Benzodiazepine Prescribing for People Receiving Opioid Agonist Treatment: A Systematic Review of the Evidence
by: Catriona Matheson, et al.
Published: (2024-10-01)

Prescriber opioid patterns following cesarean section pre and post provider training
by: Alexa Cohen, et al.
Published: (2021-12-01)

A prospective cohort of treatment-seeking patients with problematic use of prescription narcotic drugs: study protocol and baseline characteristics
by: Sofia Burmester, et al.
Published: (2024-12-01)

Realities of opioid and gabapentinoid deprescribing in socioeconomically disadvantaged communities: a qualitative evaluation
by: Charlotte L Parbery-Clark, et al.
Published: (2025-04-01)

How do contraindications to non-opioid analgesics and opioids affect the likelihood that patients with back pain diagnoses in the primary care setting receive an opioid prescription? An observational cross-sectional study
by: Michelle S. Keller, et al.
Published: (2021-02-01)

Impact of guidance issued during COVID-19 to expand take-home doses of opioid agonist treatment (OAT) in Ireland: protocol for a population-based analysis of prescribing practices and patient outcomes 2018 to 2023 [version 2; peer review: 1 approved, 2 approved with reservations]
by: Suzi Lyons, et al.
Published: (2025-04-01)

Do gabapentin or pregabalin directly modulate the µ receptor?
by: Preeti Manandhar, et al.
Published: (2021-04-01)

PREVALENCIA DE PATOLOGÍA RESPIRATORIA CRÓNICA EN PACIENTES MAYORES DE 75 AÑOS EN TRATAMIENTO CON GABAPENTINOIDES Y OPIOIDES
by: M Carmen Herrero Domínguez-Berrueta, et al.
Published: (2021-04-01)

Internet sourcing and UK end consumer trend interest in the controlled medicines (opioids, sedatives and GABA drugs) in pre and post COVID-19 timeframes
by: Mark Whitfield, et al.
Published: (2021-01-01)

Rural–urban differences in dental opioid prescribing among adolescent/young adult and adult Medicaid beneficiaries
by: Carla Shoff, et al.
Published: (2024-10-01)

Evaluation of physicians’ opioid prescribing practices, attitudes, and interactions with other healthcare professionals in optimizing opioid prescribing in Pakistan
by: Hafsa Arshad, et al.
Published: (2025-05-01)

Opioid and/or Psychotropic Use Increases Intraprocedural Sedation Drug Requirements
by: Sreeja Sanampudi, et al.
Published: (2022-04-01)

Trends in Opioid and Non-opioid Prescriptions in Austria (2016–2021): A Nationwide Study on Utilization and Concomitant Benzodiazepine Use
by: Aylin Bilir, et al.
Published: (2025-05-01)

Recreational prescription opioid misuse among college students in the USA: An application of the theory of planned behavior
by: Robert E. Davis, et al.
Published: (2019-11-01)

Comparative Effectiveness of Opioids and Opioid Substitutes on Pain and Health Related Quality of Life Among Cancer Survivors
by: Shirley K. Chan Sanchez, et al.
Published: (2025-09-01)

Prescription opioid use in Israel – the tide has risen, but it’s not a tidal wave
by: Yehuda Neumark, et al.
Published: (2024-10-01)

Post-Amputation Pain: Combined Analyses of Randomized Controlled Trials Evaluating Opioids and Gabapentinoids versus Placebo
by: Arthur A, et al.
Published: (2024-10-01)

Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids
by: Payal H. Desai, PharmD, BCCCP, et al.
Published: (2021-07-01)

Prescription opioid dispensing and prescription opioid poisoning: Population data from Victoria, Australia 2006 to 2013
by: Janneke Berecki‐Gisolf, et al.
Published: (2017-02-01)

Opioid‐limiting legislation and prescribing habits of otolaryngologists among Medicare beneficiaries
by: Yun Ji Kim, et al.
Published: (2023-08-01)

Nationwide Population-Based Study About Patterns of Prescription Opioid Use and Misuse Among Young Adults in Spain
by: Pilar Carrasco-Garrido, et al.
Published: (2022-08-01)

Treatment outcomes in patients with opioid use disorder initiated by prescription: a systematic review protocol
by: Nitika Sanger, et al.
Published: (2018-01-01)

Postoperative Opioid Prescription Practices at Discharge for Pediatric Orthopaedic Patients: A Systematic Review
by: Jiwoo Park, BA, et al.
Published: (2024-11-01)

Prescription Trends in Complex Regional Pain Syndrome: A Retrospective Case–Control Study
by: Suzanna Shermon, et al.
Published: (2023-06-01)

Prevalence and practice of opioid prescription at a Swiss emergency department: 2013–2017
by: Katharina Gaertner, et al.
Published: (2020-04-01)

Impact of prerelease methadone on mortality among people with HIV and opioid use disorder after prison release: results from a randomized and participant choice open-label trial in Malaysia
by: Alexander R. Bazazi, et al.
Published: (2022-11-01)

Opioid use and disposal patterns of emergency department patients
by: Valerie Hoerster, et al.
Published: (2023-01-01)

Influence of SSRI and SNRI co-prescription on benzodiazepine prescription trajectories
by: Kerry L. Kinney, et al.
Published: (2025-06-01)